intradermal BoNT-A

botulinum toxin type A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intradermal BoNT-A, covering 2024-03-29 to 2024-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea [Phase 4]